Loading insider details...
Latest Form 4 (Sep 14, 2026): Grant/Award of 16,250 ARTV shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 14, 2026 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/Award | 16,250 | n/a |
| Sep 8, 2026 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/Award | 13,750 | n/a |
| Jun 5, 2026 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 35,500 | n/a |
| Jun 26, 2025 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/Award | 13,750 | n/a |
| Jun 5, 2025 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 12,800 | n/a |
| Jun 10, 2024 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 25,000 | n/a |
| Jun 7, 2023 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 25,000 | n/a |
| Jun 17, 2022 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 25,000 | n/a |
| Jul 2, 2021 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 34,000 | n/a |